| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.0009 |
| mRNA | selumetinib:UNC0638 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.14 | 0.001 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.14 | 0.001 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | 0.2 | 0.001 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.43 | 0.001 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.16 | 0.001 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | -0.22 | 0.002 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.002 |